Navigation Links
US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
Date:9/3/2008

HOUSTON, Sept. 3 /PRNewswire/ -- US Oncology Specialty, LP, the state-of-the-art pharmaceutical distribution center of US Oncology, has received the Occupational Excellence Achievement Award from the National Safety Council for its outstanding safety achievements.

The award is presented to companies who produce the "best of the best" in safety and safety performance. To be eligible, organizations must report days away from work resulting from workplace injuries or illness at a rate equal to or less than 50 percent of the Bureau of Labor Statistics (BLS) rate for their classification code. The BLS rate for US Oncology Specialty's classification code is 0.9 percent; in order to qualify the organization had to report an incident rate of .45 percent or lower. In 2007, US Oncology Specialty, employing 32 employees, achieved a lost workday incidence rate of zero percent.

US Oncology Specialty was launched in 2005 to manage the ordering and delivery of approximately $1.8 billion of pharmaceuticals each year for its affiliated network of community-based oncologists. The organization has focused on ensuring the protection of employees and patients by investing in systems and security measures that produce results. The industry-leading distribution service was the first oncology distributor to achieve the National Association of Boards of Pharmacy's (NABP) Verified-Accredited Wholesale Distributors (VAWD) accreditation to implement electronic pedigree technology, ensuring that pharmaceuticals are securely tracked, from the manufacturer to the patient, for optimum security and safety.

Additionally, the organization has twice received the Occupational Excellence Award from the Texas chapter of the National Safety Council.

About US Oncology, Inc.

US Oncology, headquartered in Houston, works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting every aspect of the cancer care delivery system -- from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,247 physicians operating in 472 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
2. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
3. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
4. US Oncology to Report 2008 Second Quarter Earnings Results
5. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
6. US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements
7. Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
8. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
9. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
10. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
11. EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... ... May 16, 2017 , ... ... availability of its new ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta enables researchers ... or high-molecular-weight DNA extraction—speeding research insights at lower cost. , “We’re very ...
(Date:5/16/2017)... Village, CA (PRWEB) , ... May 16, 2017 ... ... personalized medicine technology and cancer diagnostics, has released its ClearID Lung Cancer blood ... altered in lung cancer, this new test is designed to quickly and accurately ...
(Date:5/16/2017)... ... (PRWEB) May 16, 2017 , ... ... Chinese Association of Orthopaedic Surgeons (CAOS), long-standing development partners Invibio Biomaterial Solutions, ... interbody spine surgery workshop to help expand knowledge of the implantation of ...
(Date:5/15/2017)... ... May 15, 2017 , ... Tunnell Consulting announced that ... “The Key Role of Specifications in Process Validation,” at the Process Validation Summit ... will bring together leaders from the pharmaceutical and biotech industries to explore processes, strategies ...
Breaking Biology Technology:
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... GARDENS, Fla. , April 11, 2017 /PRNewswire/ ... management and secure authentication solutions, today announced that ... by Intelligence Advanced Research Projects Activity (IARPA) to ... IARPA,s Thor program. "Innovation has been ... and IARPA,s Thor program will allow us to ...
Breaking Biology News(10 mins):